AZN vs MBLY · P/E 28, $288.38B cap vs rev $1.89B
AstraZeneca PLC (AZN) versus Mobileye Global Inc. Class A Common Stock (MBLY) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Mobileye Global Inc. Class A Common Stock (MBLY) is a auto parts company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported MBLY revenue for 2025-12-27 was $1.89B. Net income was -$392.0M. Revenue was up 14.5% from 2024-12-28 to 2025-12-27. MBLY currently screens at market cap $12.99B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. MBLY currently screens at market cap $12.99B.
Not investment advice. Open the AZN and MBLY stock pages for the full models.
Not investment advice.